In this episode, Daniel C. Butler, MD, and Shawn G. Kwatra, MD, discuss the practical considerations for using IL-13 inhibitors to treat patients with moderate to severe atopic dermatitis, including:

• Patient candidacy considerations
• Treatment advancement strategies that go beyond topical therapies
• The importance of patient-centered care that address patients’ fears and needs
• A detailed patient case to highlight take home points

Presenter

Daniel C. Butler, MD​
Assistant Dean Student Affairs​
University of Arizona College of Medicine – Tucson​
Tucson, Arizona

Shawn G. Kwatra, MD​
Dr. Joseph W. Burnett Endowed Professor and Chair ​
Department of Dermatology​
University of Maryland School of Medicine​
Baltimore, Maryland

Program page:
https://bit.ly/4kTP04D

In this episode, Andrew F. Alexis, MD, MPH; Daniel C. Butler, MD; and Shawn G. Kwatra, MD, discuss IL-13 inhibition for treating patients with moderate to severe atopic dermatitis (AD), including:

• The available biologic therapies that specifically target IL-13
• Where these agents fall in the 2024 American Academy of Dermatology treatment algorithm
• How these agents compare to other AD therapies like topical corticosteroids and oral JAK inhibitors
• A detailed patient case to highlight take home points

Presenter

Andrew F. Alexis, MD, MPH​
Professor of Clinical Dermatology​
Weill Cornell Medical College ​
New York, New York

Daniel C. Butler, MD​
Assistant Dean Student Affairs​
University of Arizona College of Medicine – Tucson​
Tucson, Arizona

Shawn G. Kwatra, MD​
Dr. Joseph W. Burnett Endowed Professor and Chair ​
Department of Dermatology​
University of Maryland School of Medicine​
Baltimore, Maryland

Program page:
https://bit.ly/4kTP04D

Listen in as Joseph Kim, MD, MPH, MBA; Manish Shah, MD; Martha Grugel, MA, discuss how they manage the prior authorization process for antiobesity agents to improve the quality of their care delivery, including:

• The information to collect during patient visits
• The available resources to help you submit prior authorizations
• The supporting documents that are often necessary to accompany prior authorizations
• How to address denials and appeals
• When to access manufacturer-based or foundation-based financial assistance

Presenters
Joseph Kim, MD, MPH, MBA
President
Q Synthesis, LLC
Newtown, Pennsylvania

Manish Shah, MD
Clinical Associate Faculty MS1 Preceptor
University of Florida College of Medicine
Gainesville, Florida

Martha Grugel, MA
Medical Assistant
Wesley Chapel, Florida

Link to full program:
https://bit.ly/45P0v8z

In this episode, Andrew F. Alexis, MD, MPH, and Daniel C. Butler, MD, discuss the immunopathogenesis and role of IL-13 in atopic dermatitis (AD), including:

• Contributors to epidermal barrier dysfunction (eg, environmental triggers)
• IL-13 as a key cytokine in AD pathogenesis
• Targeted AD therapies that inhibit IL-13
• A detailed patient case to highlight take-home points

Presenter

Andrew F. Alexis, MD, MPH​
Professor of Clinical Dermatology​
Weill Cornell Medical College ​
New York, New York

Daniel C. Butler, MD​
Assistant Dean Student Affairs​
University of Arizona College of Medicine – Tucson​
Tucson, Arizona

Program page:
https://bit.ly/4kTP04D

In this podcast, Anne E. O’Donnell, MD, discusses the latest advances and treatment strategies for patients with non–cystic fibrosis bronchiectasis (NCFBE), including:

• Airway clearance as a foundation of NCFBE management
• Strategies to address inflammation and exacerbations
• Emerging therapies in clinical development
• How to individualize treatment to NCFBE phenotypes and endotypes

Presenter
Anne E. O’Donnell, MD
Professor of Medicine
The Nehemiah and Naomi Cohen Chair in Pulmonology Disease Research
Chief, Division of Pulmonary, Critical Care and Sleep Medicine
Georgetown University Medical Center
Washington, DC

Program page:
https://bit.ly/4mZbYsm

In this podcast, Ty J. Gluckman, MD, MHA, discusses the pivotal phase III FINEARTS-HF trial and how the treatment landscape is evolving for patients with heart failure (HF) with mildly reduced or preserved ejection fraction, including:

• The emerging role of mineralocorticoid receptor antagonists in HF care
• Finerenone’s efficacy in reducing composite cardiovascular death and worsening HF events
• Why safety must be monitored, especially considering hyperkalemia risk
• Where HF guideline recommendations lack compared with the current evidence

Presenter

Ty J. Gluckman, MD, MHA
Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS)
Providence Heart Institute
Providence Health System
Portland, Oregon

Program page:
https://bit.ly/448XcH0

In this podcast, Brett M. Elicker, MD, and David E. Griffith, MD, ATSF, FACCP, FRSM, discuss the pathophysiology of non–cystic fibrosis bronchiectasis (NCFBE), the patient burden, and best practices with diagnosing NCFBE, including:

• The vicious vortex of NCFBE (ie, airway dysfunction, inflammation, infection)
• Cough as the most significant symptom and burden
• Imaging bronchiectasis with classic and inflammatory findings
• Differentiating the causes of NCFBE to inform patient care

Presenters

Brett M. Elicker, MD
Professor of Clinical Radiology
Chief, Cardiothoracic Imaging Division
Department of Radiology & Biomedical Imaging
University of California, San Francisco
San Francisco, California

David E. Griffith, MD, ATSF, FACCP, FRSM
Professor of Medicine
Division of Mycobacterial and Respiratory Diseases
Department of Medicine
National Jewish Health
Denver, Colorado

Program page:
https://bit.ly/4mZbYsm

Listen in as Joseph Kim, MD, MPH, MBA, interviews Natalie, Orbach, PA-C, to learn about how she implemented patient-centered and individualized treatment plans to improve obesity care at her practice, including

• Discussing weight and how nutrition, physical activity, mental health, and pharmacotherapy strategies can help
• Meeting patients where they are at and offering slow, incremental changes that support long-term outcomes
• Referring patients to community resources and other professionals as need
• Sharing lessons learned for those interested in implementing similar strategies in their practice
  

Presenter

Joseph Kim, MD, MPH, MBA
President
Q Synthesis, LLC
Newtown, Pennsylvania

Natalie Orbach, PA-C
Physician Assistant
Feirtag & Ramos, PA
Lutherville, Maryland

Link to full program:
https://bit.ly/45P0v8z